LETROZ 2.5MG TABLET 5'S
By SUN PHARMACEUTICAL INDUSTRIES LTD
Contains: LETROZOLE 2.5 MG
Product Summary
| Offer Price | ₹ 139.51 |
|---|---|
| Your Savings | ₹ 24.62 (15% on MRP) |
About LETROZ 2.5MG TABLET 5'S
- LETROZ 2.5MG TABLET 5'S is a medication belonging to the class of aromatase inhibitors. It is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. LETROZ 2.5MG TABLET 5'S works by reducing the production of estrogen in the body, thereby suppressing the growth of hormone-sensitive tumors. This medication is available in oral tablet form and is typically prescribed under medical supervision.
Uses of LETROZ 2.5MG TABLET 5'S
- Helps in breast cancer
- Used for postmenopausal women
- Reduces estrogen production
- Suppresses tumor growth
How LETROZ 2.5MG TABLET 5'S Works
- LETROZ 2.5MG TABLET 5'S inhibits aromatase enzyme, decreasing estrogen levels in postmenopausal women. This helps suppress hormone receptor-positive breast cancer growth.
- LETROZ 2.5MG TABLET 5'S exerts its pharmacological effects by selectively inhibiting the aromatase enzyme. Aromatase is responsible for the conversion of androgens (primarily produced by the adrenal glands) into estrogens, such as estradiol, within peripheral tissues. By inhibiting aromatase, LETROZ 2.5MG TABLET 5'S reduces the production of estrogens, leading to decreased estrogen levels in postmenopausal women. Since hormone receptor-positive breast cancer cells require estrogen for growth, the reduction in estrogen levels helps suppress tumor growth and prevents cancer recurrence. LETROZ 2.5MG TABLET 5'S mechanism of action is specific to postmenopausal women, as they no longer produce significant amounts of estrogen through ovarian activity. This medication is administered orally as a tablet and should be taken as directed by a healthcare professional.
Dosage of LETROZ 2.5MG TABLET 5'S
- Dosage for children: LETROZ 2.5MG TABLET 5'S is not typically used in children and is primarily prescribed for postmenopausal women with breast cancer. The use of LETROZ 2.5MG TABLET 5'S in children should be determined by a qualified healthcare provider based on individual circumstances.
- Dosage for adults: The recommended dosage of LETROZ 2.5MG TABLET 5'S for adult postmenopausal women with breast cancer is generally 2.5 mg once daily, administered orally. However, the specific dosage and treatment duration may vary depending on the individual's condition and medical history. It is important to follow the prescribed dosage and consult with a healthcare professional for personalized guidance.
Side Effects Of LETROZ 2.5MG TABLET 5'S
- Hot flashes
- Fatigue
- Joint pain
- Headache
- Nausea
How to Store LETROZ 2.5MG TABLET 5'S
- Store at room temperature (between 20-25°C or 68-77°F)
- Keep in a dry place, away from moisture
- Protect from light
Frequently asked questions about LETROZ 2.5MG TABLET 5'S
LETROZ 2.5MG TABLET 5'S is primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
Common side effects of LETROZ 2.5MG TABLET 5'S include hot flashes, fatigue, joint pain, headache, and nausea.
LETROZ 2.5MG TABLET 5'S is not typically used in children and is primarily prescribed for postmenopausal women with breast cancer. Its use in children should be determined by a qualified healthcare provider.
LETROZ 2.5MG TABLET 5'S works by inhibiting the aromatase enzyme, which reduces estrogen levels in postmenopausal women, helping suppress hormone receptor-positive breast cancer growth.
LETROZ 2.5MG TABLET 5'S should be stored at room temperature (between 20-25°C or 68-77°F) in a dry place, protected from moisture and light.
LETROZ 2.5MG TABLET 5'S is contraindicated during pregnancy, as it may cause harm to the developing fetus. It should only be used under appropriate medical supervision and guidance.
Yes, LETROZ 2.5MG TABLET 5'S is classified as an aromatase inhibitor and is a type of hormonal therapy used in the treatment of hormone receptor-positive breast cancer.
LETROZ 2.5MG TABLET 5'S is primarily indicated for hormone receptor-positive breast cancer and is not typically used for other types of cancer. Its use should be determined by a healthcare professional based on individual circumstances.
References related to LETROZ 2.5MG TABLET 5'S
- HIGHLIGHTS OF PRESCRIBING INFORMATION. (n.d.). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020726s027lbl.pdf
- CDSCO. (2023). Retrieved June 14, 2023, from Cdscoonline.gov.in website: https://cdscoonline.gov.in/CDSCO/Drugs
Elvis
Reviewed on 25 Jan 2024
Elvis
Reviewed on 25 Jan 2024
Super
khunti mihir devshi
Reviewed on 13 Jan 2024
khunti mihir devshi
Reviewed on 13 Jan 2024
Best experience provided by medkart
shilpa purohit
Reviewed on 04 Sep 2023
shilpa purohit
Reviewed on 04 Sep 2023
Value for money I got a good discount on medicines
tarif Malek
Reviewed on 15 Jan 2024
tarif Malek
Reviewed on 15 Jan 2024
Good
Venkataramanamurty Inguva
Reviewed on 15 Jul 2023
Venkataramanamurty Inguva
Reviewed on 15 Jul 2023
Tarif / Service is good